Pharming announces sale of priority review voucher

[ad_1] LEIDEN, The Netherlands, June 1, 2023 /PRNewswire/ — Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that it has entered into a definitive agreement with…

Pharming Group reports financial results for full year 2022

[ad_1] LEIDEN, Netherlands, March 16, 2023 /PRNewswire/ — Total revenues increased by 3% to US$205.6 million, in line with single digit growth guidance Operating profit increased by 34% to US$18.2…

Pharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank in light of US Government announcement

[ad_1] LEIDEN, Netherlands, March 13, 2023 /PRNewswire/ — Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM) (NASDAQ: PHAR) is aware that the US Department of the Treasury, the Board of…